Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01965561 · ClinicalTrials.gov registry record · Phase 4
Performance of Junctional Tourniquets in Normal Human Volunteers
A Phase 4 study, sponsored by United States Army Institute of Surgical Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT01965561 is a Phase 4 study that has completed, run by United States Army Institute of Surgical Research. The registered enrollment target is 10 participants.
The verdict
NCT01965561, a Phase 4 study, has completed, sponsored by United States Army Institute of Surgical Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
Normal human adult volunteers wereused to investigate the performance of medical devices intended to stop junctional bleeding on the battlefield.
Interventions
- DEVICE CRoC
- DEVICE AAJT
- DEVICE JETT
- DEVICE SJT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-10 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01965561
The ClinicalTrials.gov registry entry for NCT01965561 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Institute of Surgical Research, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which CRoC is the first listed.
NCT01965561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01965561 about?
NCT01965561 is a clinical study titled "Performance of Junctional Tourniquets in Normal Human Volunteers". Normal human adult volunteers wereused to investigate the performance of medical devices intended to stop junctional bleeding on the battlefield.
What is the current status of trial NCT01965561?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2013-10. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01965561?
The interventions under investigation include: CRoC (DEVICE), AAJT (DEVICE), JETT (DEVICE), SJT (DEVICE).
Who is sponsoring clinical trial NCT01965561?
This trial is sponsored by United States Army Institute of Surgical Research, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.